VISTA Eye Specialist Revolutionizes Dry Eye Treatment with Groundbreaking Research and Advanced Technology
PETALING JAYA, Malaysia, Dec. 27, 2024 /PRNewswire/ -- VISTA Eye Specialist (VISTA), Malaysia's leading eye care provider, proudly announces a major milestone in the treatment of dry eye disease. A groundbreaking study led by Dr. Aloysius Joseph Low, Medical Director and Ms. Azarina Abdullah, Optometrist has been published in the esteemed Journal of Health Science and Medical Research. This achievement...
Momcozy Announces “Love in Action” Charity Contest Winners, Highlighting Power of Collective Action
NEW YORK, Dec. 26, 2024 /PRNewswire/ -- The global one-stop mother and baby brand Momcozy is thrilled to announce the winners of the "Love in Action" Charity Contest, a pivotal component of its holiday campaign. This initiative is designed to recognize and support charities that align with Momcozy's mission of prioritizing comfort, health, and wellbeing for mothers. The contest...
Microtech Announces First Human Case of Implantable Microsensor for Heart Failure
TEL AVIV, Israel, Dec. 26, 2024 /PRNewswire/ -- Microtech, a wholly owned subsidiary of Medinol Inc., a leader in global MedTech research and development, announced that it has initiated human clinical trials of their microsensor platform, in a trial to measure atrial pressures important for the treatment of heart failure. The first...
Japan Global Innovators’ Forum 2025
The annual meeting is returning for its second year after a successful inaugural event in 2024 TOKYO, Dec. 26, 2024 /PRNewswire/ -- Tokyo-based global media agency Pacific Bridge Media and Consulting Inc. (PBMC) is pleased to announce that the 2nd annual Japan Global Innovators' Forum (JGIF) will be held in March 2025. PBMC's solutions-focused multilingual news service J-Stories will...
IND Application for a Phase I/II Clinical Study of Anti-HER2 Bispecific ADC Subcutaneous Co-formulation JSKN033 was Approved
SUZHOU, China, Dec. 26, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that a phase I/II clinical trial (Study ID: JSKN033-102) of JSKN033, a high-concentration subcutaneous co-formulation consisting of anti-HER2 bispecific antibody-drug conjugate (ADC) and PD-L1 immune checkpoint inhibitor, has been approved by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA). This study...
Matwings Technology Raised Series A Funding of Tens of Millions USD to Redefine Protein Design
'Beyond Structure, Predicting Function' SHANGHAI, Dec. 26, 2024 /PRNewswire/ -- Recently, Shanghai Matwings Technology Co., Ltd. ('Matwings'), a global leader in AI-driven protein design, announced the successful completion of Series A funding rounds, raising tens of millions of USD, led by Qiming Venture Partners. Matwings is pioneering a new frontier in protein engineering with its proprietary AI-based general protein...
Haikou delivers mix of tradition and cutting-edge industry
BEIJING, Dec. 26, 2024 /PRNewswire/ -- A news report from China Daily: Haikou, capital of South China’s Hainan province, is a vibrant metropolis known for its bustling ports, golden beaches and profound culture. Join Michael and Ani on a scavenger hunt in Haikou to explore its unique charm！ For all...
Preliminary Results of Qilu Pharmaceutical’s Phase Ia Study on GPRC5D/CD3-Targeting Bispecific Antibody QLS32015 Unveiled at 2024 ASH Annual Meeting
JINAN, China, Dec. 25, 2024 /PRNewswire/ -- During the 66th Annual Meeting of the American Society of Hematology (ASH) held in San Diego from December 7 to 10, preliminary results from the first human trial of QLS32015, a novel anticancer drug developed by Qilu Pharmaceutical for treating relapsed/refractory multiple myeloma (RRMM), were unveiled (Poster...
Industry Partnership | Basecare Medical Group (2170.HK) and Jinghua Medical Group Sign Strategic Cooperation Agreement
SUZHOU, China, Dec. 25, 2024 /PRNewswire/ -- On December 24, 2024, Basecare Medical Group (2170.HK) held a strategic cooperation signing ceremony with Jinghua Medical Group in Shenyang. Basecare Medical possesses a comprehensive technological platform covering andrology, embryo culture, genetics, and other aspects of the entire industry chain, providing world-leading technical support aimed at enhancing Jinghua Medical's research and discipline development....
European Wellness Biomedical Group Announces New Klotho Research Initiative Led by Prof. Mike Chan
HEIDELBERG, Germany, Dec. 25, 2024 /PRNewswire/ -- European Wellness Biomedical Group (EWBG) has launched a new research initiative focused on Klotho, a protein with transformative potential in longevity medicine. Led by Professor Dr. Mike Chan, this project will explore Klotho's role in combating age-related diseases and its ability to regenerate critical organs, including...
